FQ
GHDX

First Quadrant’s Genomic Health, Inc. GHDX Stock Holding History

First Quadrant’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-12,230
Closed -$711K – 722
2019
Q2 		$711K Sell
12,230
-910
-7% -$53.9K 0.05% 352
2019
Q1 		$920K Sell
13,140
-7,631
-37% -$566K 0.07% 277
2018
Q4 		$1.34M Sell
20,771
-312
-1% -$21.9K 0.11% 192
2018
Q3 		$1.48M Buy
21,083
+20,295
+2,576% +$1.19M 0.03% 344
2018
Q2 		$40K Buy
+788
New +$31.3K ﹤0.01% 714
2017
Q4 		– Sell
-208
Closed -$7K – 1003
2017
Q3 		$7K Buy
+208
New +$6.56K ﹤0.01% 903

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

First Quadrant's GHDX Position: Q3 2019 in Review

First Quadrant sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 12,230 shares — an estimated $711K sold.

First Quadrant first reported a position in GHDX in Q3 2017 and held it in 6 quarters. The position peaked at $1.48M in Q3 2018. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

  • First Quadrant reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
  • First Quadrant sold 12,230 Genomic Health, Inc. shares in Q3 2019, an estimated $711K.
  • First Quadrant first reported a position in Genomic Health, Inc. in Q3 2017 and held it in 6 quarters.
  • First Quadrant's Genomic Health, Inc. position peaked at $1.48M in Q3 2018.
  • 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on First Quadrant's 13F filing for Q3 2019, filed 25 Oct 2019.